IMCIVREE (setmelanotide)

IMCIVREE is indicated for the treatment of obesity and the control of hunger associated with pro-opiomelanocortin (POMC), including PCSK1, deficiency obesity or leptin receptor (LEPR) deficiency obesity in adults and children 6 years of age and older.

www.imcivree.com